Aier Eye Hospital Group Co., Ltd. (SHE: 300015)

Market Cap	115.75B
Revenue (ttm)	20.62B
Net Income (ttm)	3.63B
Shares Out	9.30B
EPS (ttm)	0.39
PE Ratio	31.78
Forward PE	31.20
Dividend	0.15 (1.21%)
Ex-Dividend Date	Jun 6, 2024

Volume	53,230,172
Average Volume	58,369,061
Open	12.42
Previous Close	12.42
Day's Range	12.40 - 12.64
52-Week Range	9.05 - 19.09
Beta	0.72
RSI	36.47
Earnings Date	Apr 25, 2025

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates ophthalmic hospitals in mainland China, Europe, the United States, Hong Kong, and Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2007
• Employees: 36,718
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300015

Financial Performance

In 2023, Aier Eye Hospital Group's revenue was 20.37 billion, an increase of 26.43% compared to the previous year's 16.11 billion. Earnings were 3.36 billion, an increase of 33.07%.